Fructose Sodium Bisphosphate Tablets

Previous Names

English Name

FRUCTOSE

DIPHOSPHATE

SODIUM

TABLETS

PINYLICAL NAME

GUOTANG

ERLINSUANNA

PIAN

Drug class

Other

Traits

Pharmacology and toxicology

This product is a cellular metabolite present in the body that regulates the activity of various enzyme systems in glucose metabolism. It has been reported that exogenous sodium fructose diphosphate can increase the intracellular concentration of adenosine triphosphate and phosphocreatine and promote the inward flow of potassium ions by activating the activities of phosphofructokinase and pyruvate kinase, which is beneficial to the energy metabolism and glucose utilization of cells under ischemia and hypoxia, thus reducing the damage of ischemic myocardium.

Pharmacokinetics

Indications

For myocardial ischemia, angina pectoris, cerebral infarction adjuvant therapy.

Use and dosage

Adverse reactions

Mainly manifested as mild symptoms of the digestive system, such as abdominal distension, nausea, burning sensation in the epigastric region, scanty stools, etc., which can be tolerated by the patients in general, and there is no need to stop the drug.

Contraindications

Allergy to the product, hyperphosphatemia and renal failure is prohibited.

Precautions

It is advisable to take it after meals in patients with severe ulcer disease.

Drugs for pregnant and lactating women

It is not known.

Children

Elderly patients

Drug interactions

Unknown.

Specification: 0.25g